HER2 Support Group Forums - View Single Post - Monogram And Dana-Farber Cancer Institute Initiate Evaluation Of HERmark(TM) Breast C

News · 09-24-2008, 03:21 AM

Monogram Biosciences, Inc. (Nasdaq: MGRM) announced that it has initiated a study, in collaboration with the Dana-Farber Cancer Institute (DFCI), to evaluate Monogram's HERmark(TM) Breast Cancer Assay in metastatic breast cancer.

More...

09-24-2008, 03:21 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,987	Monogram And Dana-Farber Cancer Institute Initiate Evaluation Of HERmark(TM) Breast C Monogram Biosciences, Inc. (Nasdaq: MGRM) announced that it has initiated a study, in collaboration with the Dana-Farber Cancer Institute (DFCI), to evaluate Monogram's HERmark(TM) Breast Cancer Assay in metastatic breast cancer. More...